Browsing Tag
biologics manufacturing
8 posts
WuXi Biologics wins EMA approval in Ireland as WuXiUP automation signals new chapter in global biologics manufacturing
WuXi Biologics secures EMA approval in Ireland and achieves WuXiUP automated continuous production, reinforcing global dual sourcing and biomanufacturing innovation.
Why Shilpa’s bet on Alveolus Bio may reshape the future of pulmonary biologics
Shilpa Medicare leads funding round in Alveolus Bio to accelerate Phase 2 COPD trials and first-in-human studies for novel inhaled therapeutics.
Syngene expands global footprint with US biologics manufacturing facility acquisition
Syngene International Limited, a leading contract research, development, and manufacturing organization (CRDMO), has acquired its first biologics manufacturing…
Can WuXi Biologics’ new EffiX platform transform microbial expression? Here’s what to know
WuXi Biologics has introduced the EffiX platform, an advanced microbial expression system designed to enhance the production of…
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing…
MilliporeSigma invests over €300m in new South Korean bioprocessing center
MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has earmarked…
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global…
Syngene International launches Syngene Manufacturing Solutions to expand contract manufacturing capabilities
Discover how Syngene International’s new subsidiary is set to boost its end-to-end manufacturing capabilities in pharmaceuticals and biologics—read more now.